JL

Jupiter Life Line Hospitals Ltd

Q2 FY27Healthcare Services

Jupiter Life Line Hospitals Q2 Results 2026: PAT ₹56 Cr −2%

Q2 FY27 earnings call: what management said on revenue, margins and capex.

Revenue
₹456Cr
+15.7% YoY
+10.9% QoQ
Net profit
₹56Cr
−1.8% YoY
+47.4% QoQ
Margin
23%
0 pp YoY
+4 pp QoQ

What the Q2 FY27 call signalled

2 of 3 strong

RevenueModerate growth
CapexCapex planned
FundraiseFundraise planned
Price₹287
Market cap₹9.4K Cr
P/E49.5

The short version

Existing hospitals (Thane, Pune, Indore) continue to perform in line with expectations, with stable or modest growth.

From Jupiter Life Line Hospitals Ltd's Q2 FY27 earnings-call transcript · updated 6 Nov 2026.

How did Jupiter Life Line Hospitals' revenue grow in the September 2026 quarter?

Moderate growth
  • Existing hospitals (Thane, Pune, Indore) continue to perform in line with expectations, with stable or modest growth.
  • Dombivli facility is ramping up well, with increasing medical admissions contributing to improving occupancy and near EBITDA break-even; transplants and radiation oncology services expected to start in upcoming quarters, further driving growth.
  • Bed additions planned at Indore and possibly Thane once occupancies reach mid-60%+, signaling incremental capacity expansion.
  • Annual maintenance capex anticipated at INR10-20 crores per unit, focusing on equipment replacement rather than major expansions.
  • New projects (Pune South, Mira Road, BKC) under various stages of development, with capex funding planned from internal accruals and term loan utilisation, supporting medium-term growth.

2 more points from Jupiter Life Line Hospitals Ltd's call on revenue

Create a free account to keep reading this call

What happened to Jupiter Life Line Hospitals' margins in Q2 FY27?

EBITDA to net cash conversion has averaged around 70% in recent years but could moderate to around 60%…

Locked: what Jupiter Life Line Hospitals Ltd said on margins

Also locked on this page: fundraising

Free account, 30 seconds. No card needed.

What capex is Jupiter Life Line Hospitals planning?

Capex planned
  • Current Capex:
  • Pune South hospital: INR220 crores spent so far, plus INR100 crores for land acquisition.
  • Mira Road: Land purchased; around INR75-80 crores spent, mostly in regulatory phase; major capex to begin post-construction start.
  • Ongoing Projects: Funds from a secured INR500 crores term loan will be primarily used for Pune South, Mira Road, and BKC projects.
  • Maintenance Capex: Estimated at INR10-20 crores per unit annually, mainly for replacing biomedical equipment over a 10-year cycle.
  • Future Expansion:
  • Addition of beds planned at Indore once occupancy reaches mid-60s%.

2 more points from Jupiter Life Line Hospitals Ltd's call on capex

Create a free account to keep reading this call

Top-ranked in Healthcare Services

Ranked on what management guided this quarter

Guidance-ranked
Rev 1Mar 1
Rev 1Mar 3
3
Rev 2Mar 1
4
Rev 2Mar 1
5
Rev 2Mar 1
Sign up free to see 3 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Is Jupiter Life Line Hospitals raising money or cutting debt?

Current focus is on utilizing existing resources, including a secured INR500 crore term loan.

Locked: what Jupiter Life Line Hospitals Ltd said on fundraising

Also locked on this page: margins

Free account, 30 seconds. No card needed.

How big is Jupiter Life Line Hospitals' order book?

The discussion primarily revolves around operational performance, hospital expansions, capex incurred, insurance empanelment, occupancy rates, and financial metrics. - Focus was on land acquisition for Pune South hospital and ongoing regulatory processes for Mira Road and BKC projects. - Capex details were shared, e.g., INR220 crores spent on Pune hospital, INR75-80 crores on Mira Road land (regulatory phase). If order book data is crucial, it may require direct inquiry or review of other company filings or presentations.

Jupiter Life Line Hospitals Ltd — Quarterly revenue & net profit

Revenue Net profit
Jun 2025Q1 FY26
Sep 2025Q2 FY26
Dec 2025Q3 FY26
Mar 2026Q4 FY26
Jun 2026Q1 FY27
Sep 2026Q2 FY27

Jupiter Life Line Hospitals Ltd Q2 FY27 results — key figures

Jupiter Life Line Hospitals Ltd Q2 FY27 reported results vs Q2 FY26, ₹ crore
₹ CrQ2 FY27Q2 FY26YoYQ1 FY27QoQ
Revenue456394+15.7%411+10.9%
Operating profit (EBITDA)10792+16.3%79+35.4%
Operating margin23%23%0 pp19%+4 pp
Profit before tax7574+1.4%51+47.1%
Net profit (PAT)5657-1.8%38+47.4%
EPS (₹)1.711.75-2.3%1.14+50%

Source: reported quarterly figures (Screener), ₹ crore.

Reported quarterly figures (₹ Cr). Latest (Q2 FY27): revenue ₹456 Cr, net profit ₹56 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

More Q2 FY27 results in Healthcare Services

All Q2 FY27 results | Healthcare Services rankings

Others in Healthcare Services this season

  • Park Medi World (Q2 FY27)

    other income) was ₹5,110 mn, a 25% YoY increase from ₹4,102 mn in Q2 FY’26. Key investor presentation takeaways from Park Medi World Ltd's Q2 FY27 investor pres

  • Gaudium IVF (Q2 FY27)

    Revenue from operations for quarter ended September 30, 2026: ₹3,741.11 lakhs (Consolidated), ₹2,805.68 lakhs (Standalone) . Key results statement takeaways fro

  • Nephro Care (Q2 FY27)

    Income from IPD Services: ₹1,915.45 Lakhs . Key results statement takeaways from Nephro Care India Ltd's Q2 FY27 results statement — and how it ranks against se

  • Lotus Eye Hospit (Q2 FY27)

    1,303.84 lakhs for the quarter ended September 30, 2025, indicating a year-on-year increase of approximately 36%. Key results statement takeaways from Lotus Eye

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Arthneeti Pro · Annual

Jupiter Life Line Hospitals Ltd and 15K+ more earnings calls,
for less than your morning chai

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access

Frequently Asked Questions

What were Jupiter Life Line Hospitals Ltd Q2 FY27 results?

Existing hospitals (Thane, Pune, Indore) continue to perform in line with expectations, with stable or modest growth.

What is Jupiter Life Line Hospitals Ltd share price analysis?

Jupiter Life Line Hospitals Ltd currently shows a below-average growth signal. The stock trades at a P/E of 49.5 with a market cap of ₹9,394 Cr. Investors should review the full earnings analysis for detailed insights.

Is Jupiter Life Line Hospitals Ltd planning capital expenditure?

Current Capex:.

Keep Jupiter Life Line Hospitals Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.